Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pre-menopausal Breast Cancer × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5717 Neoplasms 366 Ovarian Neoplasms 267 Triple Negative Breast Neoplasms 249 Prostatic Neoplasms 247 Lung Neoplasms 238 Neoplasm Metastasis 224 Colorectal Neoplasms 223 Carcinoma, Non-Small-Cell Lung 191 Breast Neoplasms, Male 187 Motor Activity 149 Colonic Neoplasms 146 Pancreatic Neoplasms 143 Melanoma 132 Carcinoma, Intraductal, Noninfiltrating 124 Head and Neck Neoplasms 114 Stomach Neoplasms 110 Uterine Cervical Neoplasms 109 Fatigue 90 Breast Carcinoma In Situ 89 Carcinoma, Ovarian Epithelial 87 Lymphedema 85 Endometrial Neoplasms 84 Carcinoma, Renal Cell 82 Urinary Bladder Neoplasms 81 Pain 79 Sarcoma 76 Lymphoma, Non-Hodgkin 74 Small Cell Lung Carcinoma 73 Lymphoma 72

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡